Recurrent Vaginal Cancer: Clinical Trials

2 trials for Recurrent Vaginal Cancer, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed. 2 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 22Completed 2

Follow Recurrent Vaginal Cancer: new trials by email Literature Review of Recurrent Vaginal Cancer trials Research Report on Recurrent Vaginal Cancer

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Triapine, Cisplatin, and Radiation Therapy in Treating Patients With Cervical Cancer or Vaginal Cancer
triapine, cisplatin, external beam radiation therapy - Recurrent Cervical Cancer, Recurrent Vaginal Cancer
Phase 2CompletedNational Cancer Institute (NCI)262009-07-012017-11-17
Stereotactic Radiosurgery Using CyberKnife in Treating Women With Advanced or Recurrent Gynecological Malignancies
stereotactic radiosurgery, quality-of-life assessment - Fallopian Tube Cancer, Ovarian Sarcoma
Phase 2CompletedCase Comprehensive Cancer Center502009-05-012013-11-28

Narrower conditions

Uterine Cervical Neoplasms (2)  ·  Vaginal Neoplasms (2)  ·  Carcinoma, Ovarian Epithelial (1)  ·  Endometrial Neoplasms (1)  ·  Fallopian Tube Neoplasms (1)  ·  Vulvar Neoplasms (1)

Broader conditions

Female Urogenital Diseases (2)  ·  Female Urogenital Diseases and Pregnancy Complications (2)  ·  Genital Diseases (2)  ·  Genital Diseases, Female (2)  ·  Genital Neoplasms, Female (2)  ·  Neoplasms (2)  ·  Neoplasms by Site (2)  ·  Urogenital Diseases (2)  ·  Urogenital Neoplasms (2)  ·  Uterine Cervical Diseases (2)  ·  Uterine Diseases (2)  ·  Uterine Neoplasms (2)  ·  Vaginal Diseases (2)  ·  Adnexal Diseases (1)  ·  Carcinoma (1)

Interventions

2-phenyl-6-(2'-(4'-(ethoxycarbonyl)thiazolyl))thiazolo(3,2-b)(1,2,4)triazole (1)  ·  3-aminopyridine-2-carboxaldehyde thiosemicarbazone (1)  ·  Cisplatin (1)  ·  Fluorodeoxyglucose F18 (1)  ·  Magnetic Resonance Spectroscopy (1)  ·  Radiosurgery (1)

Sponsors

Case Comprehensive Cancer Center (1)  ·  National Cancer Institute (NCI) (1)

Countries

United States (2)

Top investigators

Charles Kunos (1)  ·  Robert DeBernardo, MD (1)

Results publications

PMID 22105720, PMID 36185311

NIH funding

P30CA043703 (1), U01CA062502 (1)